Showing results (251-260 of 324) with videos related to

Sort By:
Pageof 33
British Journal of Cancer|October 27, 2012
Association of creatine kinase and skin toxicity in phase I trials of anticancer agentsV Moreno Garcia, P Thavasu, M Blanco Codesido, et al.
Clinical and Translational Radiation Oncology|August 4, 2018
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumoursM T Dillon, Z Boylan, D Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2008
Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma groupM Schlemmer, P Reichardt, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumoursJ-Y Blay, A Le Cesne, J Verweij, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancerJ R Ramsay, N M Bleehen, I Dennis, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2018
Prognostic relevance of distant metastases versus locally advanced disease in soft tissue sarcomas: An EORTC-STBSG database studyA J Verschoor, S Litière, S Marréaud, et al.
Cancer Research|August 1, 1990
Decreased NADPH:cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditionsP R Hoban, M I Walton, C N Robson, et al.
Anti-Cancer Drug Design|June 1, 1996
Synthesis and biological evaluation of a series of tyrphostins containing nitrothiophene moieties as possible epidermal growth factor receptor tyrosine kinase inhibitorsV G Brunton, L R Kelland, M J Lear, et al.
The Journal of Antibiotics|May 1, 1992
C-13 beta-acyloxymilbemycins, a new family of macrolides. Discovery, structural determination and biological propertiesM A Haxell, B F Bishop, P Bryce, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2006
A phase I study of intravenous TZT-1027 administered on day 1 and day 8 of a three-weekly cycle in combination with carboplatin given on day 1 alone in patients with advanced solid tumoursA Greystoke, S Blagden, A L Thomas, et al.
Pageof 33